Related references
Note: Only part of the references are listed.Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma
David M. Cognetti et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)
Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy
Takuya Kato et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Near-Infrared Photoimmunotherapy: Photoactivatable Antibody-Drug Conjugates (ADCs)
Hisataka Kobayashi et al.
BIOCONJUGATE CHEMISTRY (2020)
Theoretical and Experimental Studies on the Near-Infrared Photoreaction Mechanism of a Silicon Phthalocyanine Photoimmunotherapy Dye: Photoinduced Hydrolysis by Radical Anion Generation
Masato Kobayashi et al.
CHEMPLUSCHEM (2020)
Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death
Ligia C. Gomes-da-Silva et al.
ONCOIMMUNOLOGY (2020)
Near-Infrared Photoimmunotherapy of Cancer
Hisataka Kobayashi et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Photoinduced Ligand Release from a Silicon Phthalocyanine Dye Conjugated with Monoclonal Antibodies: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy
Kazuhide Sato et al.
ACS CENTRAL SCIENCE (2018)
Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity
Mikako Ogawa et al.
ONCOTARGET (2017)
Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
Makoto Mitsunaga et al.
NATURE MEDICINE (2011)
Silicon Phthalocyanine (Pc 4) Photodynamic Therapy Is a Safe Modality for Cutaneous Neoplasms: Results of a Phase 1 Clinical Trial
Elma D. Baron et al.
LASERS IN SURGERY AND MEDICINE (2010)
Share Paper
